Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes
BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other…
BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other…
BenevolentAI has raised a massive second round of fundraising to expand the drug developing capabilities…
The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to…
Lundbeck is acquiring Prexton Therapeutics in a deal that could reach up to €905M if…
Today we're in Ghent, Belgium, home to several successful biotechs, including Ablynx, to visit ADx…
Researchers have found two proteins that could be used to treat Parkinson's disease patients by…
Synpromics and UCL will collaborate to develop a gene therapy to treat Parkinson's disease that…
Hummingbird Diagnostics has teamed up with Saarland University to develop molecular diagnostics that can detect…
A decade of work has culminated in researchers reconstructing a protein that is key to…
Prexton Therapeutics has launched a Phase II trial to test whether its drug foliglurax can treat…
Prothena and Roche are advancing their Parkinson's antibody to Phase II, triggering a new milestone…
UPDATE (12/05/2017): Newron has received €11.3M as a milestone payment for the approval from its…